Gregoire Sylvie 4
4 · CervoMed Inc. · Filed Nov 17, 2025
Insider Transaction Report
Form 4
CervoMed Inc.CRVO
Gregoire Sylvie
Director10% Owner
Transactions
- Purchase
Common Stock
2025-11-13$7.51/sh+4,447$33,397→ 1,471,578 total - Purchase
Common Stock
2025-11-14$7.57/sh+1,707$12,922→ 1,473,285 total - Purchase
Common Stock
2025-11-14$7.55/sh+1,693$12,782→ 1,693 total(indirect: By Spouse)
Footnotes (4)
- [F1]Shares purchased in open-market transactions.
- [F2]Shares held jointly by the Reporting Person and his spouse, Dr. John Alam, M.D., the Issuer's President & Chief Executive Officer and a member of the Issuer's Board of Directors.
- [F3]Includes 1,707 shares held by the Sylvie Gregoire Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.44 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.
- [F4]Includes 1,693 shares held by the John J. Alam Roth IRA. The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $7.41 to $7.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.